Downloads: 301

Files in This Item:
File Description SizeFormat 
11_532.pdf2.94 MBAdobe PDFView/Open
Full metadata record
DC FieldValueLanguage
dc.contributor.author稲田, 務ja
dc.contributor.author桐山, 啻夫ja
dc.contributor.alternativeINADA, Tsutomuja
dc.contributor.alternativeKIRIYAMA, Tadaoja
dc.date.accessioned2010-05-24T01:49:43Z-
dc.date.available2010-05-24T01:49:43Z-
dc.date.issued1965-06ja
dc.identifier.issn0018-1994ja
dc.identifier.urihttp://hdl.handle.net/2433/112757-
dc.description.abstractTen patients following circumcision of the phimosi s , 9 patients after operations of the intrascrotal contents and 21 patients endotracheally anaesthetized with GOF were orally administered 120-160mg "Bromelain" per day for a week. A 5 aged girl with adrenogenital syndrome underwent amputation of the enlarged clitoris followed by administration of "Bromelain" 20 mg a day for 10 days . The median duration of consulting visits to our clinic following circumcision was 9.1 days for 10 patients received "Bromelain" and 11.2 days for 11 controls. The average period necessiated for disapperance of all laryngeal symptoms• .caused by endotracheal anaesthesia was 1.9 days for 21 patients given "Bro melain" and 4.0 days for 14 controls. The effect of "Bromelain" on postoperative edema was satisfactory. A 33-year-old man with posttraumatic priapism was excellently treated with 1120 mg of "Bromelain" alone . Daily administrat i on of "Bromelain" for 18 to 30 days, totalling 2,000 to 4,320 mg, to 5 patients with marked macro-pyuria due to chronic inflammation of the urinary tracts and /or disturbance of urinary passage, who had been refractory to long-term therapy of su lfa drugs or anitbiotics, resulted complete release from subjective symptoms and improvement in grade of the pyuria. Results of b l eeding time, coagulation time, clot retraction, capillary fragility, and tromboplastin generation test in8 patients given a total of 1,920 to 4,320mg of "Bromelain" orally during periods between 16 to 33 days showed no significant changes. In all cases but one, thrombocyte count increased insignificantly following the medication. Prothrombin activity in 2 patients decreased to 49% and 31% respectively after the administration while the other 6 patients remained within normal limits. In all of the 48 patients studied, no undisirable side effects were experienced.ja
dc.format.mimetypeapplication/pdfja
dc.language.isojpnja
dc.publisher泌尿器科紀要刊行会ja
dc.subjectAdultja
dc.subjectBlood Coagulation/drug effectsja
dc.subjectBromelains/pharmacology/therapeutic useja
dc.subjectChild, Preschoolja
dc.subjectClinical Trials as Topicja
dc.subjectFemaleja
dc.subjectGenitalia/surgeryja
dc.subjectHumansja
dc.subjectMaleja
dc.subject.ndc494.9ja
dc.titleP-741(Bromelain)の泌尿器科領域における応用と血液凝固機転に及ぼす影響についての2,3の検討ja
dc.title.alternativeUrological evaluations of "bromelain" and clinical studies on its influences for blood coagulationja
dc.type.niitypeDepartmental Bulletin Paperja
dc.identifier.ncidAN00208315ja
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume11ja
dc.identifier.issue6ja
dc.identifier.spage532ja
dc.identifier.epage545ja
dc.textversionpublisherja
dc.sortkey12ja
dc.address京都大学医学部泌尿器科教室ja
dc.address京都大学医学部泌尿器科教室ja
dc.address.alternativethe Department of Urology, Faculty of Medicine, Kyoto Uuiversityja
dc.address.alternativethe Department of Urology, Faculty of Medicine, Kyoto Uuiversityja
dc.identifier.pmid5318607ja
Appears in Collections:Vol.11 No.6

Show simple item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.